000 03450nam a22004695i 4500
001 978-3-7091-0912-0
003 DE-He213
005 20140220082925.0
007 cr nn 008mamaa
008 120817s2013 au | s |||| 0|eng d
020 _a9783709109120
_9978-3-7091-0912-0
024 7 _a10.1007/978-3-7091-0912-0
_2doi
050 4 _aRC952-954.6
072 7 _aMJX
_2bicssc
072 7 _aMED032000
_2bisacsh
082 0 4 _a618.97
_223
082 0 4 _a612.67
_223
100 1 _aWehling, Martin.
_eeditor.
245 1 0 _aDrug Therapy for the Elderly
_h[electronic resource] /
_cedited by Martin Wehling.
264 1 _aVienna :
_bSpringer Vienna :
_bImprint: Springer,
_c2013.
300 _aXV, 356 p. 53 illus., 35 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aForeword -- Part 1: General aspects -- Part 2: Special considerations with regard to organ systems based on geriatric clinical importance -- Part 3: Pharmacotherapy and geriatric syndromes -- Part 4: Further problem areas in gerontopharmacotherapy and pragmatic recommendations.
520 _aWith people aged 65 years and older currently making up the fastest growing age group throughout the world, the demographic revolution of an aging society will inevitably lead to increased pressure to develop a rationalistic and age-tailored process of diagnosis and treatment among the elderly. As aging people often suffer from several chronic diseases and are being treated with multiple medications concurrently, unwanted drug interactions occur more frequently. Whereas recent approaches have recommended to remove particular drugs from the medication regimen to avoid adverse effects, Drug Therapy for the Elderly underlines both indispensable and dispensable elements of drug treatment, providing the practitioner with: - Background information on the elderly population regarding their needs for particular drugs (with an eye to frailty, co-morbidity patterns, and special sensitivities regarding drug metabolism and excretion) - Practical advice about drug treatment surveillance parameters in the elderly - In-depth discussion of drugs in relation to the elderly with specific diagnoses - Integration of multimorbidity/polypharmacy situations into prioritization schemes - A plan for how to deal with the complexity of polypharmacy situations in a five-minute consultation An original classification of drugs is proposed by the editor which relates the power of effects, prognostic data, and tolerability to a prioritization scoring system. This approach is the first to not only provide a negative listing, but also integrates positive data into an overall assessment for drugs fit for the aged. Therefore, Drug Therapy for the Elderly serves as a timely reference for a wide array of physicians.
650 0 _aMedicine.
650 0 _aToxicology.
650 0 _aGeriatrics.
650 0 _aInternal medicine.
650 1 4 _aMedicine & Public Health.
650 2 4 _aGeriatrics/Gerontology.
650 2 4 _aInternal Medicine.
650 2 4 _aPharmacology/Toxicology.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783709109113
856 4 0 _uhttp://dx.doi.org/10.1007/978-3-7091-0912-0
912 _aZDB-2-SME
999 _c98956
_d98956